This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Leibniz-Institut Fur Analytische Wissenschaften - Isas - E.v.. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Thilo Bracht: Innovator in Cholangiocellular Carcinoma Research
Introduction
Thilo Bracht is a notable inventor based in Bochum, Germany. He has made significant contributions to the field of medical diagnostics, particularly in the identification of biomarkers for cholangiocellular carcinoma (CCC). His work is crucial for advancing the diagnosis and treatment of this challenging cancer type.
Latest Patents
Thilo Bracht holds a patent related to biomarkers for cholangiocellular carcinoma. The invention outlines a method for identifying specific marker proteins that serve as biomarkers for CCC. This patent not only details the biomarkers identified but also discusses their applications in diagnosis, surveillance, and treatment. Furthermore, it includes a diagnostic device that utilizes these biomarkers and a screening assay aimed at identifying novel pharmaceutical compounds for the treatment of CCC. He has 1 patent to his name.
Career Highlights
Thilo Bracht is affiliated with the Leibniz Institute for Analytical Sciences (ISAS) in Germany. His work at this prestigious institution has allowed him to collaborate with other experts in the field and contribute to significant advancements in cancer research.
Collaborations
Thilo has worked alongside notable colleagues such as Helmut E Meyer and Dominik Megger. Their combined expertise enhances the research efforts at ISAS and contributes to the development of innovative diagnostic methods.
Conclusion
Thilo Bracht's contributions to the field of cholangiocellular carcinoma research exemplify the impact of innovation in medical science. His work on biomarkers is paving the way for improved diagnostic and treatment options for patients suffering from this disease.